Labcorp Announces Board Changes and Officer Appointments
Ticker: LH · Form: 8-K · Filed: Nov 19, 2024 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Labcorp Holdings Inc. (LH) |
| Form Type | 8-K |
| Filed Date | Nov 19, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.10, $725,000, $400,000, $200,000, $1,920,000 b |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, officer-appointment, board-changes
TL;DR
Labcorp's board is changing, with new directors and officers appointed. Keep an eye on compensation details.
AI Summary
Labcorp Holdings Inc. announced on November 15, 2024, a change in its board of directors, including the election of new directors and the appointment of certain officers. The filing also disclosed compensatory arrangements for these officers and included a Regulation FD disclosure. Financial statements and exhibits were also filed as part of this report.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing primarily concerns routine corporate governance updates and does not indicate any immediate financial distress or significant operational changes.
Key Players & Entities
- LABCORP HOLDINGS INC. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- November 15, 2024 (date) — Date of earliest event reported
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of directors and departure of certain officers, but specific names and the exact number of changes are detailed within the full report and exhibits.
Were there any new officer appointments?
Yes, the filing explicitly mentions the appointment of certain officers.
What is the significance of the Regulation FD disclosure?
A Regulation FD disclosure ensures that material non-public information is broadly disseminated to the public, preventing selective disclosure.
What types of financial statements and exhibits were filed?
The filing states that Financial Statements and Exhibits were included, but the specific content of these exhibits would require further examination of the full document.
When was the company incorporated?
The company was incorporated in Delaware.
Filing Stats: 1,037 words · 4 min read · ~3 pages · Grade level 11 · Accepted 2024-11-19 07:13:51
Key Financial Figures
- $0.10 — nge on which registered Common Stock , $0.10 par value LH New York Stock Exchange
- $725,000 — , Ms. Wang's annual base salary will be $725,000. For calendar year 2025, Ms. Wang will
- $400,000 — ng will also receive a sign-on bonus of $400,000, $200,000 of which will be payable thir
- $200,000 — so receive a sign-on bonus of $400,000, $200,000 of which will be payable thirty days af
- $1,920,000 b — rds in an amount determined by dividing $1,920,000 by the average of the closing share price
- $640,000 — h an aggregate grant-date fair value of $640,000 determined using the Black-Scholes valu
- $640,000 b — its in an amount determined by dividing $640,000 by the average of the closing share price
Filing Documents
- lh-20241115.htm (8-K) — 29KB
- exhibit991pr111924.htm (EX-99.1) — 10KB
- lc2020logov2.gif (GRAPHIC) — 5KB
- 0000920148-24-000121.txt ( ) — 173KB
- lh-20241115.xsd (EX-101.SCH) — 2KB
- lh-20241115_lab.xml (EX-101.LAB) — 22KB
- lh-20241115_pre.xml (EX-101.PRE) — 12KB
- lh-20241115_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On November 19, 2024, Labcorp issued a press release announcing Mr. Eisenberg's expected retirement and the appointment of Ms. Wang. A copy of that press release is attached hereto as Exhibit 99.1.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press Release dated November 19, 2024 issued by Labcorp Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABCORP HOLDINGS INC. Registrant By: /s/ SANDRA VAN DER VAART Sandra van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary November 19, 2024